Lipidomics Applications for Discovering Biomarkers of Diseases in Clinical Chemistry

International Review of Cell and Molecular Biology

Volumn 313, Issue , 2014, Pages 1-26

  Zhao, Ying Yong ^a,b   Cheng, Xian long ^d   Lin, Rui Chao ^c  

^a NORTHWEST UNIVERSITY   (China)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

^d NATIONAL INSTITUTES FOR FOOD AND DRUG CONTROL   (China)

Author keywords

Clinical chemistry; Disease biomarker; Lipid profiling; Lipidomics; Mass spectrometry

Indexed keywords

BIOLOGICAL MARKER; LIPID; TUMOR MARKER;

ALZHEIMER DISEASE; ANALYTIC METHOD; ARTICLE; ATHEROSCLEROSIS; CANCER RESEARCH; CARDIOVASCULAR DISEASE; CLINICAL CHEMISTRY; CLINICAL RESEARCH; DATA ANALYSIS; DIABETES MELLITUS; DIAGNOSIS; ELECTROSPRAY; HUMAN; KIDNEY DISEASE; LIPID ANALYSIS; LIPIDOMICS; LIPOGENESIS; LIQUID LIQUID EXTRACTION; LUNG DISEASE; NEOPLASM; NEUROPSYCHIATRY; OBESITY; PHASE SEPARATION; SOLID PHASE EXTRACTION; ANIMAL; CARDIOVASCULAR DISEASES; KIDNEY DISEASES; LIPID METABOLISM; LUNG DISEASES; MENTAL DISORDERS; METABOLISM; METABOLOMICS; NEOPLASMS; PREDICTIVE VALUE; PROCEDURES;

ANIMALS; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; HUMANS; KIDNEY DISEASES; LIPID METABOLISM; LIPIDS; LUNG DISEASES; MENTAL DISORDERS; METABOLOMICS; NEOPLASMS; PREDICTIVE VALUE OF TESTS; TUMOR MARKERS, BIOLOGICAL;

EID: 84908893413     PISSN: 19376448     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-800177-6.00001-3     Document Type: Chapter

References (91)

1. Astarita G., Piomelli D. Towards a whole-body systems [multi-organ] lipidomics in Alzheimer's disease. Prostagl. Leukot. Essent. Fat. Acids 2011, 85(5):197-203.
2. Batal I., Ericsoussi M.B., Cluette-Brown J.E., O'Sullivan B.P., Freedman S.D., Savaille J.E., Laposata M. Potential utility of plasma fatty acid analysis in the diagnosis of cystic fibrosis. Clin. Chem. 2007, 53(1):78-84.
3. Bligh E.G., Dyer W.J. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 1959, 37(11):911-917.
4. Bobeldijk I., Hekman M., de Vries-van der Weij J., Coulier L., Ramaker R., Kleemann R., Kooistra T., Rubingh C., Freidig A., Verheij E. Quantitative profiling of bile acids in biofluids and tissues based on accurate mass high resolution LC-FT-MS: compound class targeting in a metabolomics workflow. J. Chromatogr. B 2008, 871(2):306-313.
5. Brown H.A., Murphy R.C. Working towards an exegesis for lipids in biology. Nat. Chem. Biol. 2009, 5(9):602-606.
6. Chan R.B., Oliveira T.G., Cortes E.P., Honig L.S., Duff K.E., Small S.A., Wenk M.R., Shui G., Di Paolo G. Comparative lipidomic analysis of mouse and human brain with Alzheimer disease. J. Biol. Chem. 2012, 287(4):2678-2688.
7. Chen H., Miao H., Feng Y.L., Zhao Y.Y., Lin R.C. Metabolomics in dyslipidemia. Adv. Clin. Chem 2014, 66:101-119.
8. Chen S., Hoene M., Li J., Li Y., Zhao X., Häring H.U., Schleicher E.D., Weigert C., Xu G., Lehmann R. Simultaneous extraction of metabolome and lipidome with methyl tert-butyl ether from a single small tissue sample for ultra-high performance liquid chromatography/mass spectrometry. J. Chromatogr. A 2013, 1298:9-16.
9. Christiem W.W. Gas Chromatography and Lipids. A Practical Guide 1989, The Oily Press, Bridgewater, England.
10. de Gómez Dumm N.T., Giammona A.M., Touceda L.A., Raimondi C. Lipid abnormalities in chronic renal failure patients undergoing hemodialysis. Med. (B Aires) 2001, 61(2):142-146.
11. Deeley J.M., Mitchell T.W., Wei X., Korth J., Nealon J.R., Blanksby S.J., Truscott R.J. Human lens lipids differ markedly from those of commonly used experimental animals. Biochim. Biophys. Acta-Mol. Cell. Biol. Lip 2008, 1781(6-7):288-298.
12. Del Boccio P., Pieragostino D., Di Ioia M., Petrucci F., Lugaresi A., De Luca G., Gambi D., Onofrj M., Di Ilio C., Sacchetta P., Urbani A. Lipidomic investigations for the characterization of circulating serum lipids in multiple sclerosis. J. Proteomics 2011, 74(12):2826-2836.
13. Ekroos K. Lipidomics: Technologies and Applications 2012, Wiley-VCH Verlag GmbH & Co, Weinheim, German.
14. Fahy E., Subramaniam S., Brown H.A., Glass C.K., Merrill A.H., Murphy R.C., Raetz C.R., Russell D.W., Seyama Y., Shaw W., Shimizu T., Spener F., van Meer G., VanNieuwenhze M.S., White S.H., Witztum J.L., Dennis E.A. A comprehensive classification system for lipids. J. Lipid Res. 2005, 46(5):839-862.
15. Fahy E., Subramaniam S., Murphy R.C., Nishijima M., Raetz C.R., Shimizu T., Spener F., van Meer G., Wakelam M.J., Dennis E.A. Update of the LIPID MAPS comprehensive classification system for lipids. J. Lipid Res. 2009, 50(S):9-14.
16. Folch J., Ascoli I., Lees M., Meath J.A., Le B.N. Preparation of lipid extracts from brain tissue. J. Biol. Chem. 1951, 191(2):833-841.
17. Fritscher L.G., Post M., Rodrigues M.T., Silverman F., Balter M., Chapman K.R., Zamel N. Profile of eicosanoids in breath condensate in asthma and COPD. J. Breath. Res. 2012, 6(2):026001.
18. Goss V., Hunt A.N., Postle A.D. Regulation of lung surfactant phospholipid synthesis and metabolism. Biochim. Biophys. Acta-Mol. Cell. Biol. Lip. 2013, 1831(2):448-458.
19. Goto-Inoue N., Hayasaka T., Zaima N., Setou M. Imaging mass spectrometry for lipidomics. Biochim. Biophys. Acta-Mol. Cell. Biol. Lip 2011, 1811(11):961-969.
20. Graessler J., Schwudke D., Schwarz P.E., Herzog R., Shevchenko A., Bornstein S.R. Top-down lipidomics reveals ether lipid deficiency in blood plasma of hypertensive patients. Plos One 2009, 4(7):e6261.
21. Gregory K.E., Bird S.S., Gross V.S., Marur V.R., Lazarev A.V., Walker W.A., Kristal B.S. Method development for fecal lipidomics profiling. Anal. Chem. 2013, 85(2):1114-1123.
22. Guerrera I.C., Astarita G., Jais J.P., Sands D., Nowakowska A., Colas J., Sermet-Gaudelus I., Schuerenberg M., Piomelli D., Edelman A., Ollero M. A novel lipidomic strategy reveals plasma phospholipid signatures associated with respiratory disease severity in cystic fibrosis patients. Plos One 2009, 4(11):e7735.
23. Guo X., Lankmayr E. Multidimensional approaches in LC and MS for phospholipid bioanalysis. Bioanalysis 2010, 2(6):1109-1123.
24. Han X. Multi-dimensional mass spectrometry-based shotgun lipidomics and the altered lipids at the mild cognitive impairment stage of Alzheimer's disease. Biochim. Biophys. Acta-Mol. Cell. Biol. Lip 2010, 1801(8):774-783.
25. Han X., Gross R.W. Global analyses of cellular lipidomes directly from crude extracts of biological samples by ESI mass spectrometry: a bridge to lipidomics. J. Lipid Res. 2003, 44(4):1071-1079.
26. Han X., Rozen S., Boyle S.H., Hellegers C., Cheng H., Burke J.R., Welsh-Bohmer K.A., Doraiswamy P.M., Kaddurah-Daouk R. Metabolomics in early Alzheimer's disease: identification of altered plasma sphingolipidome using shotgun lipidomics. Plos One 2011, 6(7):e21643.
27. Han X., Yang J., Cheng H., Ye H., Gross R.W. Toward fingerprinting cellular lipidomes directly from biological samples by two-dimensional electrospray ionization mass spectrometry. Anal. Biochem. 2004, 330(2):317-331.
28. Henriksene K., O'Bryant S.E., Hampel H., Trojanowski J.Q., Montine T.J., Jeromin A., Blennow K., Lönneborg A., Wyss-Coray T., Soares H., Bazenet C., Sjögren M., Hu W., Lovestone S., Karsdal M.A., Weiner M.W. The future of blood-based biomarkers for Alzheimer's disease. Alzheimer's Dementia 2014, 10(1):115-131.
29. Higashi N., Mita H., Ono E., Fukutomi Y., Yamaguchi H., Kajiwara K., Tanimoto H., Sekiya K., Akiyama K., Taniguchi M. Profile of eicosanoid generation in aspirin-intolerant asthma and anaphylaxis assessed by new biomarkers. J. Allergy Clin. Immunol. 2010, 125(5):1084-1091.
30. Hu C., Kong H., Qu F., Li Y., Yu Z., Gao P., Peng S., Xu G. Application of plasma lipidomics in studying the response of patients with essential hypertension to antihypertensive drug therapy. Mol. Biosyst. 2011, 7(12):3271-3279.
31. Isaacm G. Development of Enhanced Analytical Methodology for Lipid Analysis from Sampling to Detection. A Targeted Lipidomics Approach 2005, Uppsala University, Sweden.
32. Iuliano L., Pacelli A., Ciacciarelli M., Zerbinati C., Fagioli S., Piras F., Orfei M.D., Bossù P., Pazzelli F., Serviddio G., Caltagirone C., Spalletta G. Plasma fatty acid lipidomics in amnestic mild cognitive impairment and Alzheimer's disease. J. Alzheimers Dis. 2013, 36(3):545-553.
33. Ivanova P.T., Milne S.B., Myers D.S., Brown H.A. Lipidomics: a mass spectrometry based, systems level analysis of cellular lipids. Curr. Opin. Chem. Biol. 2009, 13(5-6):525-531.
34. Jackson J.E. A User's Guide to Principal Components 1991, Wiley, New York.
35. Jia L., Wang C., Zhao S., Lu X., Xu G. Metabolomic identification of potential phospholipid biomarkers for chronic glomerulonephritis by using high performance liquid chromatography-mass spectrometry. J. Chromatogr. B 2007, 860(1):134-140.
36. Kaluzny M.A., Duncan L.A., Merritt M.V., Epps D.E. Rapid separation of lipid classes in high yield and purity using bonded phase columns. J. Lipid Res. 1985, 26(1):135-140.
37. Katajamaa M., Miettinen J., Oresic M. MZmine: toolbox for processing and visualization of mass spectrometry based molecular profile data. Bioinformatics 2006, 22(5):634-636.
38. Kim H.Y., Salem N. Separation of lipid classes by solid phase extraction. J. Lipid Res. 1990, 31(12):2285-2289.
39. Kim I.C., Lee J.H., Bang G., Choi S.H., Kim Y.H., Kim K.P., Kim H.K., Ro J. Lipid profiles for HER2-positive breast cancer. Anticancer Res. 2013, 33(6):2467-2472.
40. Kliman M., May J.C., McLean J.A. Lipid analysis and lipidomics by structurally selective ion mobility-mass spectrometry. Biochim. Biophys. Acta-Mol. Cell. Biol. Lip 2011, 1811(11):935-945.
41. Lankinen M., Schwab U., Erkkilä A., Seppänen-Laakso T., Hannila M.L., Mussalo H., Lehto S., Uusitupa M., Gylling H., Oresic M. Fatty fish intake decreases lipids related to inflammation and insulin signaling-a lipidomics approach. Plos One 2009, 4(4):e5258.
42. Löfgren L., Ståhlman M., Forsberg G.B., Saarinen S., Nilsson R., Hansson G.I. The BUME method: a novel automated chloroform-free 96-well total lipid extraction method for blood plasma. J. Lipid Res. 2012, 53(8):1690-1700.
43. Lundström S.L., Balgoma D., Wheelock Å.M., Haeggström J.Z., Dahlén S.E., Wheelock C.E. Lipid mediator profiling in pulmonary disease. Curr. Pharm. Biotechnol. 2011, 12(7):1026-1052.
44. Luque-García J.L., Luque de Castro M.D. Focused microwave-assisted Soxhlet extraction: devices and applications. Talanta 2004, 64(3):571-577.
45. Luque-García J.L., Luque de Castro M.D. Ultrasound-assisted Soxhlet extraction: an expeditive approach for solid sample treatment. Application to the extraction of total fat from oleaginous seeds. J. Chromatogr. A 2004, 1034(1-2):237-242.
46. McCombie G., Browning L.M., Titman C.M., Song M., Shockcor J., Jebb S.A., Griffin J.L. omega-3 oil intake during weight loss in obese women results in remodelling of plasma triglyceride and fatty acids. Metabolomics 2009, 5(3):363-374.
47. McEvoy J., Baillie R.A., Zhu H., Buckley P., Keshavan M.S., Nasrallah H.A., Dougherty G.G., Yao J.K., Kaddurah-Daouk R. Lipidomics reveals early metabolic changes in subjects with schizophrenia: effects of atypical antipsychotics. Plos One 2013, 8(7):e68717.
48. Meikle P.J., Wong G., Tsorotes D., Barlow C.K., Weir J.M., Christopher M.J., MacIntosh G.L., Goudey B., Stern L., Kowalczyk A., Haviv I., White A.J., Dart A.M., Duffy S.J., Jennings G.L., Kingwell B.A. Plasma lipidomic analysis of stable and unstable coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 2011, 31(11):2723-2732.
49. Metz T.O., Zhang Q., Page J.S., Shen Y., Callister S.J., Jacobs J.M., Smith R.D. The future of liquid chromatography-mass spectrometry (LC-MS) in metabolic profiling and metabolomic studies for biomarker discovery. Biomark. Med. 2007, 1(1):159-185.
50. Min H.K., Lim S., Chung B.C., Moon M.H. Shotgun lipidomics for candidate biomarkers of urinary phospholipids in prostate cancer. Anal. Bioanal. Chem. 2011, 399(2):823-830.
51. Mitchell T.W., Pham H., Thomas M.C., Blanksby S.J. Identification of double bond position in lipids: from GC to OzID. J. Chromatogr. B 2009, 877(26):2722-2735.
52. Moco S., Bino R.J., De Vos R.C.H., Vervoort J. Metabolomics technologies and metabolite identification. Trend. Anal. Chem. 2007, 26(9):855-866.
53. Navas-Iglesias N., Carrasco-Pancorbo A., Cuadros-Rodríguez L. From lipid analysis towards lipidomics, a new challenge for the analytical chemistry of the 21st century. Part I: modern lipid analysis. Trend. Anal. Chem. 2009, 28(4):393-403.
54. Nguyen H.N., Son D.J., Lee J.W., Hwang D.Y., Kim Y.K., Cho J.S., Lee U.S., Yoo H.S., Moon D.C., Oh K.W., Hong J.T. Mutant presenilin 2 causes abnormality in the brain lipid profile in the development of Alzheimer's disease. Arch. Pharm. Res. 2006, 29(10):884-889.
55. Niemelä P.S., Castillo S., Sysi-Aho M., Oresic M. Bioinformatics and computational methods for lipidomics. J. Chromatogr. B 2009, 877(26):2855-2862.
56. Nygren H., Seppänen-Laakso T., Castillo S., Hyötyläinen T., Orešič M. Liquid chromatography-mass spectrometry LC-MS-based lipidomics for studies of body fluids and tissues. Meth. Mol. Biol. 2011, 708:247-257.
57. Ollero M., Astarita G., Guerrera I.C., Sermet-Gaudelus I., Trudel S., Piomelli D., Edelman A. Plasma lipidomics reveals potential prognostic signatures within a cohort of cystic fibrosis patients. J. Lipid Res. 2011, 52(5):1011-1022.
58. Ollero M., Guerrera I.C., Astarita G., Piomelli D., Edelman A. New lipidomic approaches in cystic fibrosis. Methods Mol. Biol. 2011, 742:265-278.
59. Orešič M., Seppänen-Laakso T., Sun D., Tang J., Therman S., Viehman R., Mustonen U., van Erp T.G., Hyötyläinen T., Thompson P., Toga A.W., Huttunen M.O., Suvisaari J., Kaprio J., Lönnqvist J., Cannon T.D. Phospholipids and insulin resistance in psychosis: a lipidomics study of twin pairs discordant for schizophrenia. Genome Med. 2012, 4(1):1.
60. Oresic M. Bioinformatics and computational approaches applicable to lipidomics. Eur. J. Lipid. Sci. Technol. 2009, 111(1):99-106.
61. Pizarro C., Arenzana-Rámila I., Pérez-del-Notario N., Pérez-Matute P., González-Sáiz J.M. Plasma lipidomic profiling method based on ultrasound extraction and liquid chromatography mass spectrometry. Anal. Chem. 2013, 85(24):12085-12092.
62. Powell W.S. Rapid extraction of arachidonic acid metabolites from biological samples using octadecylsilyl silica. Methods Enzymol. 1982, 86:467-477.
63. Risé P., Volpi S., Colombo C., Padoan R.F., D'Orazio C., Ghezzi S., Melotti P., Bennato V., Agostoni C., Assael B.M., Galli C. Whole blood fatty acid analysis with micromethod in cystic fibrosis and pulmonary disease. J. Cyst. Fibros. 2010, 9(3):228-233.
64. Ruiz-Gutiérrez V., Pérez-Camino M.C. Update on solid-phase extraction for the analysis of lipid classes and related compounds. J. Chromatogr. A 2000, 885(1-2):321-341.
65. Sabbagh M.N., Sandhu S., Kolody H., Lahti T., Silverberg N.B., Sparks D.L. Studies on the effect of the apolipoprotein E genotype on the lipid profile in Alzheimer's disease. Curr. Alzheimer Res. 2006, 3(2):157-160.
66. Sanak M., Gielicz A., Bochenek G., Kaszuba M., Nizankowska-Mogilnicka E., Szczeklik A. Targeted eicosanoid lipidomics of exhaled breath condensate provide a distinct pattern in the aspirin-intolerant asthma phenotype. J. Allergy Clin. Immunol. 2011, 127(5):1141-1147.
67. Schwab U., Seppänen-Laakso T., Yetukuri L., Agren J., Kolehmainen M., Laaksonen D.E., Ruskeepää A.L., Gylling H., Uusitupa M., Oresic M. Triacylglycerol fatty acid composition in diet-induced weight loss in subjects with abnormal glucose metabolism-the GENOBIN study. Plos One 2008, 3(7):e2630.
68. Schwarz E., Prabakaran S., Whitfield P., Major H., Leweke F.M., Koethe D., McKenna P., Bahn S. High throughput lipidomic profiling of schizophrenia and bipolar disorder brain tissue reveals alterations of free fatty acids, phosphatidylcholines, and Ceramides. J. Proteome Res. 2008, 7(10):4266-4277.
69. Self R. Extraction of Organic Analytes from Foods 2005, The Royal Society of Chemistry, Cambridge, UK.
70. Shahidi F., Wanasundara P.K.J.P.D. Extraction and analysis of lipids. Food Lipids 2002, Marcel Dekker, New York, NY, USA. C.C. Ahoh, D.B. Min (Eds.).
71. Spener F., Lagarde M., Geloen A., Record M. What is lipidomics?. Eur. J. Lipid Sci. Technol. 2003, 105(9):481-482.
72. Ståhlman M., Ejsing C.S., Tarasov K., Perman J., Borén J., Ekroos K. High-throughput shotgun lipidomics by quadrupole time-of-flight mass spectrometry. J. Chromatogr. B 2009, 877(26):2664-2672.
73. Stegemann C., Drozdov I., Shalhoub J., Humphries J., Ladroue C., Didangelos A., Baumert M., Allen M., Davies A.H., Monaco C., Smith A., Xu Q., Mayr M. Comparative lipidomics profiling of human atherosclerotic plaques. Circ. Cardiovasc. Genet. 2011, 4(3):232-242.
74. Stübiger G., Aldover-Macasaet E., Bicker W., Sobal G., Willfort-Ehringer A., Pock K., Bochkov V., Widhalm K., Belgacem O. Targeted profiling of atherogenic phospholipids in human plasma and lipoproteins of hyperlipidemic patients using MALDI-QIT-TOF-MS/MS. Atherosclerosis 2012, 224(1):177-186.
75. Subramaniam S., Fahy E., Gupta S., Sud M., Byrnes R.W., Cotter D., Dinasarapu A.R., Maurya M.R. Bioinformatics and systems biology of the lipidome. Chem. Rev. 2011, 111(10):6452-6490.
76. Sylvan K., Kačer P., Vilhanová B., Kuzma M., Lipovová P., Fenclová Z., Lebedová J., Pelclová D. Determination of cysteinyl leukotrienes in exhaled breath condensate: method combining immunoseparation with LC-ESI-MS/MS. J. Chromatogr. B 2011, 879(23):2220-2228.
77. Touboul D., Gaudin M. Lipidomics of Alzheimer's disease. Bioanalysis 2014, 6(4):541-561.
78. Van der Spoel D., Marklund E.G., Larsson D.S., Caleman C. Proteins, lipids, and water in the gas phase. Macromol. Biosci.. 2011, 11(1):50-59.
79. van Meer G. Cellular lipidomics. EMBO J. 2005, 24(18):3159-3165.
80. Wenk M.R. The emerging field of lipidomics. Nat. Rev. Drug. Discov. 2005, 4(7):594-610.
81. Wiswedel I. F2-isoprostanes: sensitive biomarkers of oxidative stress invitro and invivo: a gas chromatography-mass spectrometric approach. Methods Mol. Biol. 2009, 580:3-16.
82. Wood P.L. Mass spectrometry strategies for clinical metabolomics and lipidomics in psychiatry, neurology, and neuro-oncology. Neuropsychopharmacology 2014, 39(1):24-33.
83. Wrona M., Mauriala T., Bateman K.P., Mortishire-Smith R.J., O'Connor D. 'All-in-One' analysis for metabolite identification using liquid chromatography/hybrid quadrupole time-of-flight mass spectrometry with collision energy switching. Rapid Commun. Mass Spectrom. 2005, 19(18):2597-2602.
84. Yetukuri L., Ekroos K., Vidal-Puig A., Oresic M. Informatics and computational strategies for the study of lipids. Mol. Biosyst. 2008, 4(2):121-127.
85. Zhao Y.Y., Lin R.C. Metabolomics in nephrotoxicity. Adv. Clin. Chem. 2014, 65:69-89.
86. Zhao Y.Y. Metabolomics in chronic kidney disease. Clin. Chim. Acta 2013, 422:59-69.
87. E. J. Proteome Res. 2013, 12(2):692-703.
88. E application in disease biomarker discovery: the discoveries in proteomics to metabolomics. Chem. Biol. Int. 2014, 215(1):7-16.
89. Zhou X., Mao J., Ai J., Deng Y., Roth M.R., Pound C., Henegar J., Welti R., Bigler S.A. Identification of plasma lipid biomarkers for prostate cancer by lipidomics and bioinformatics. Plos One 2012, 7(11):e48889.
90. Zhou X., Mao J., He Z., Henegar J. Lipidomics in identifying lipid biomarkers of prostate cancer. FASEB J. 2010, 24:354.6.
91. Zhu C., Liang Q.L., Hu P., Wang Y.M., Luo G.A. Phospholipidomic identification of potential plasma biomarkers associated with type 2 diabetes mellitus and diabetic nephropathy. Talanta 2011, 85(4):1711-1720.